InnoCan Pharma Corporation (CSE:INNO)
5.76
-0.48 (-7.69%)
Apr 30, 2026, 10:02 AM EST
InnoCan Pharma Market Cap
InnoCan Pharma has a market cap or net worth of CAD 25.91 million as of May 1, 2026. Its market cap has decreased by -51.72% in one year.
Market Cap
25.91M
Enterprise Value
21.64M
Revenue
36.49M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.76
Market Cap Chart
Since September 25, 2019, InnoCan Pharma's market cap has increased from 1.06M to 25.91M, an increase of 2,338.89%. That is a compound annual growth rate of 62.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 25.91M | -14.03% |
| Dec 30, 2025 | 30.14M | -49.98% |
| Dec 31, 2024 | 60.26M | -27.47% |
| Dec 29, 2023 | 83.08M | 54.74% |
| Dec 30, 2022 | 53.69M | -72.99% |
| Dec 31, 2021 | 198.79M | 218.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Loblaw Companies | 72.12B |
| Dollarama | 46.27B |
| George Weston | 36.55B |
| Metro | 18.84B |
| Eastwood Bio-Medical Canada | 44.78M |
| Nepra Foods | 44.75M |
| Burcon NutraScience | 30.08M |
| Inter-Rock Minerals | 24.12M |